NeOnc signs $50M strategic partnership with Quazar and acquires AI/quantum IP for $3.5M

NEONC TECHNOLOGIES HOLDINGS, INC.

Quazar to acquire 1.4M NeOnc shares at $25/share ($35M); $15M for UAE clinical trials and infrastructure.
Initial $400k subscription for 2.5M NuroMENA shares; future $50M round at $25/share could dilute NeOnc's stake to ~38%.
Definitive LOI to acquire AI, 3D bioprinting, and quantum modeling IP from Dr. Ishwar K. Puri for $3.5M ($500k cash + $3M stock).
Dr. Ishwar K. Puri appointed to NeOnc's Board of Directors; he is USC SVP of Research and Innovation, top 0.4% scholar globally.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.